Sonoma Pharmaceuticals, Inc. Logo

Sonoma Pharmaceuticals, Inc.

Develops products based on patented, stabilized hypochlorous acid (HOCl) technology.

SNOA | US

Overview

Corporate Details

ISIN(s):
US83558L2043
LEI:
Country:
United States of America
Address:
5445 CONESTOGA COURT, SUITE 150, 80301 BOULDER

Description

Sonoma Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and commercializes products based on its patented Microcyn® Technology, a stabilized hypochlorous acid (HOCl) platform. With over 20 years of experience, the company produces a range of prescription and over-the-counter solutions for advanced wound care, dermatology, animal health, and eye care. Its products are designed to manage various conditions by promoting healing and reducing the risk of infection. The portfolio serves healthcare professionals in settings like hospitals and nursing homes, as well as consumers for at-home use.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2026-01-02 18:25 English 7.2 KB
2026-01-02 18:24 English 7.2 KB
2026-01-02 18:22 English 7.2 KB
2026-01-02 18:22 English 7.2 KB
2026-01-02 18:21 English 7.2 KB
2026-01-02 18:20 English 7.1 KB
2026-01-02 18:18
CURRENT REPORT
English 65.2 KB
2025-11-04 09:46
FORM 10-Q FOR SEP 2025
English 840.9 KB
2025-10-23 19:00
FORM 8-K
English 66.6 KB
2025-10-09 18:30
CURRENT REPORT
English 179.2 KB
2025-09-29 18:30
CURRENT REPORT
English 17.4 MB
2025-09-26 19:01
CURRENT REPORT
English 286.9 KB
2025-09-26 19:00
PROSPECTUS SUPPLEMENT
English 127.4 KB
2025-08-29 18:37
FORM 8-K
English 67.8 KB
2025-08-07 18:02
FORM 10-Q FOR JUNE 2025
English 790.9 KB

Automate Your Workflow. Get a real-time feed of all Sonoma Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Sonoma Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Sonoma Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.